Randomized Phase II Trial of Endocrine Therapy with or Without Ribociclib after Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptora-Positive, Human Epidermal Growth Factor Receptor 2a-Negative Metastatic Breast Cancer: MAINTAIN Trial

Kevin Kalinsky, Melissa K. Accordino, Codruta Chiuzan, Prabhjot S. Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S. Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea N. Baer, Sun Y. Oh, Amelia B. Zelnak, Kari B. Wisinski, Eleni Andreopoulou, William J. Gradishar, Erica Stringer-Reasor, Sonya A. Reid, Anne O'DeaRuth O'Regan, Katherine D. Crew, Dawn L. Hershman

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Phase II Trial of Endocrine Therapy with or Without Ribociclib after Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptora-Positive, Human Epidermal Growth Factor Receptor 2a-Negative Metastatic Breast Cancer: MAINTAIN Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences